• Bausch Health Companies Inc BHC.TO reported quarterly adjusted earnings of 91 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 89 cents. The mean expectation of six analysts for the quarter was for earnings of 94 cents per share. Wall Street expected results to range from 82 cents to $1.10 per share.

• Revenue rose 5.3% to $2.53 billion from a year ago; analysts expected $2.48 billion.

• Bausch Health Companies Inc's reported EPS for the quarter was 40 cents​.

• The company reported quarterly net income of $148 million.

• Bausch Health Companies Inc shares had risen by 2.4% this quarter and lost 15.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 5.3% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 5 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is "buy."

• Wall Street's median 12-month price target for Bausch Health Companies Inc is $7.00, about 8.7% above its last closing price of $6.39

This summary was machine generated from LSEG data July 30 at 11:40 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)